Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Investing.com - Voyager Therapeutics Inc (NASDAQ: VYGR) reported third quarter EPS of $-0.160, $0.29 better than the analyst estimate of $-0.450. Revenue for the quarter came in at $24.63M versus the consensus estimate of $11.7M.
Voyager Therapeutics Inc's stock price closed at $6.83. It is up 5.560% in the last 3 months and up 8.760% in the last 12 months.
Voyager Therapeutics Inc saw 3 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Voyager Therapeutics Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Voyager Therapeutics Inc's Financial Health score is "great performance".
Check out Voyager Therapeutics Inc's recent earnings performance, and Voyager Therapeutics Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar